Market Tracker

05/29 6:45pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

33.95
Delayed Data
As of May 29
 +0.10 / +0.30%
Today’s Change
31.56
Today|||52-Week Range
40.50
-0.32%
Year-to-Date

Today’s Trading

Previous close33.85
Today’s open33.93
Day’s range33.75 - 34.21
Volume536,399
Average volume (3 months)681,567
Market cap$2.4B
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-40.00%
Earnings growth (next 5 years)+13.17%
Revenue growth (last year)+26.92%
P/E ratio27.0
Price/Sales3.31
Price/Book3.47

Competitors

 Today’s
change
Today’s
% change
--COSMO Pharmaceutical...+1.20+0.75%
TSROTESARO Inc+1.02+1.77%
GWPHGW Pharmaceuticals P...-0.09-0.08%
INSYINSYS Therapeutics I...-0.78-1.29%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)$0.41
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts